$50.37
-1.30-2.52%
At close: Jun 5, 5:00 PM EST
$50.37
N/A
After Hours: 4:00 PM EST
AnaptysBio Inc Earnings Estimates
ANABNASDAQ
AnaptysBio Earnings Estimates, EPS & Revenue | NASDAQ:ANAB
AnaptysBio (ANAB) is scheduled to report Q2 earnings on August 5, 2026. Analysts estimate EPS of $0.30 and quarterly revenue of $20.67M.
In the most recent quarter (Q1), AnaptysBio reported EPS of $-1.84, missing estimates of $-0.66 by 1.79%. Revenue came in at $25.56M, exceeding the estimate of $18.87M by 0.35%.
Over the last 4 quarters, AnaptysBio has averaged an EPS surprise of 1.02% and a revenue surprise of 0.81%.
Earnings Date
Aug 5
EPS Estimate
$0.300
Quarterly Revenue Estimate
$20.67M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$232.39M
AnaptysBio Earnings History
Analyze the earnings history of AnaptysBio using advanced sorting and filters.
Loading calendar...
AnaptysBio (ANAB) Earnings Per Share
The chart below shows AnaptysBio's reported EPS compared to analyst estimates over recent quarters.
AnaptysBio (ANAB) Revenue
The chart below shows AnaptysBio's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is AnaptysBio (NASDAQ:ANAB) reporting earnings?
AnaptysBio (ANAB) is scheduled to report earnings on August 5, 2026. The last reported earnings were for reported on May 12, 2026 for Q1.
What were the latest earnings per share (EPS) for AnaptysBio (NASDAQ:ANAB)?
The Actual EPS was $-1.84, which missed the estimate of $-0.66.
What were AnaptysBio’s (NASDAQ:ANAB) revenues?
The Actual Revenue was $25.56M, which beat the estimate of $18.87M.
